1) deferrization therapy
去铁治疗
2) deferoxamine/therapeutic use
去铁胺/治疗应用
3) androgen deprivation therapy
去势治疗
1.
Survey on quality of life following medicine androgen deprivation therapy in prostate cancer patients;
47例前列腺癌药物去势治疗后对生活质量影响的调查
2.
Research advances in the role of bisphosphonates in preventing BMD loss in hormone-sensitive prostate cancer patients undergoing androgen deprivation therapy;
双磷酸盐对接受去势治疗的激素敏感型前列腺癌患者防治骨质丢失的研究进展
3.
Objective To investigate the application effects of evidence-based nursing against mental depression in the elderly patients with prostate cancer after androgen deprivation therapy(ADT).
目的探讨老年前列腺癌去势治疗患者抑郁心理的循证护理措施。
4) ablative therapy
去除治疗
1.
Objective:To evaluate whether an 185MBq diagnostic dose of 131 I produces a visually apparent stunning effect 72h before 131I ablative therapy with post-thyroidectomy patients for differentiated thyroid carcinoma.
结论 :13 1I去除治疗前 72h进行 185MBq的13 1I全身诊断性显像与甲状腺组织顿抑无关 ,可以有效地应
5) iron chelation
祛铁治疗
1.
Now the drugs for iron chelation therapy include deferoxamine,deferiprone and deferasirox.
输血依赖的患者应定期监测体内铁过载的情况,并及时进行祛铁治疗。
6) ~(131)I ablation therapy
131I去除治疗
补充资料：去铁胺
分子式：C25H48N6O8
分子量：暂无
CAS号：70-51-9
性质：暂无
制备方法：暂无
用途：解毒药。
分子量：暂无
CAS号：70-51-9
性质：暂无
制备方法：暂无
用途：解毒药。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条